Biotest
Dr Ramroth is Chairman of the Board of Management since May, 2019 - a member of the Board of Management since 2004. He joined Biotest in 2003 from a position as Chairman for Business Development at Metallgesellschaft Technologies AG. From 1999 he had worked as CFO for the same company. He was CEO of CeramTec AG from 1997 to 1999 and Director of Business Development at Metallgesellschaft AG from 1990 to 1997. Dr Ramroth is an attorney and has a doctorate in economics. Dr. Michael Ramroth was born in 1961.
This person is not in any offices
Biotest
Biotest AG is a Germany-based provider of plasma proteins and biological drugs. The Company, with a chain that extends from pre-clinical and clinical development to worldwide marketing and distribution, mainly specializes in the areas of clinical immunology, hematology and intensive care medicine. Biotest AG develops, manufactures and markets immunoglobulin, coagulation factors and albumins based on human blood plasma. These are used for diseases of the immune and hematopoietic systems. In addition, the Company develops monoclonal antibodies in the indications of cancer of plasma cells and systemic lupus erythematosus, which are produced by recombinant technologies.